Loading clinical trials...
Loading clinical trials...
Stress Hyperglycemia as an Indicator for Future Diabetes Mellitus: A Prospective Cohort Study
We hypothesize that stress hyperglycemia is an indicator that a patient will develop type 2 diabetes mellitus in the future. Subjects who are not diabetic are enrolled and blood glucose readings reviewed during their intensive care unit stay. All subjects are consented and have a HbA1C level drawn to determine if they have diabetes mellitus or not. They are then followed up in 1 year and the HbA1C repeated to determine if they have developed diabetes mellitus over the course.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Yale New Haven Hospital St. Raphael Campus
New Haven, Connecticut, United States
Norwalk Hospital
Norwalk, Connecticut, United States
Start Date
February 1, 2013
Primary Completion Date
March 1, 2015
Completion Date
March 1, 2015
Last Updated
September 5, 2016
1
ACTUAL participants
Lead Sponsor
Yale University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03821636